Just doing some digging on pancreatic. Abraxane showed 5/67 with CR's in a P2 combo with gemcitabine. Median survival 10.3 months vs 6.4 months for THLD. http://ca.news.finance.yahoo.com/s/31052009/34/biz-f-business-wire-new-data-demonstrate-anti-tumor-activity-abraxane-combination.html